Sunshine Heart said today it is looking at therapeutic strategies focused on neuromodulation rather than counterpulsation, touting the shift as a more cost effective strategy with a faster path to commercialization for its C-Pulse system.
The C-Pulse system is designed to use intra-aortic balloon counter-pulsation to reduce the load on the left ventricle, using a cuff around the exterior of the aorta designed to inflate and deflate in sync with the heart’s pulsation to augment cardiac function.
